To include your compound in the COVID-19 Resource Center, submit it here.

Team ties target to GBM progression, identifies biomarker

In a paper published in Cancer Cell, researchers at Massachusetts Institute of Technology and Harvard Medical School used an in vivo short hairpin RNA screen to

Read the full 262 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE